Study: Death rate from cancer drops 27 percent over last 25 years
January 14, 2019 | Samantha Bonar
The overall cancer death rate has dropped by 27 percent over the last 25 years, according to data released last week by the American Cancer Society. City of Hope's James Lacey, Ph.D., M.P.H., breaks down the results.
Clinical research nurses: ‘Shepherds’ of the CAR T program
January 9, 2019 | Abe Rosenberg
What's it like to work at the center of a true medical and scientific revolution? It's emotional, often overwhelming. But it’s also a place to witness miracles. Such is the life of the clinical research nurses who staff City of Hope's CAR T cell program.
CAR T for CNS lymphoma: Early research shows promise
December 12, 2018 | Cara Martinez
Xiuli Wang, Ph.D., research professor at City of Hope, presented encouraging research on using CAR T cell therapy for central nervous system lymphoma at this year's American Society of Hematology conference.
City of Hope investigators present breakthrough research at 60th American Society of Hematology meeting
December 5, 2018 | Letisia Marquez
Physicians and researchers at the 2018 American Society of Hematology conference presented clinical trials for new leukemia and lymphoma treatments, laying the groundwork for innovative therapeutic approaches aimed at improving treatment options and quality of life for patients.
Patient beats back AML with novel therapy after unusual recurrence
November 26, 2018 | Malcolm Bedell
Fourteen years after “beating” acute myeloid leukemia, Donald Brust and his longtime oncologist, City of Hope’s Vinod A. Pullarkat, M.D., were startled to learn through routine bloodwork that his cancer was back.
Caltech-City of Hope Biomedical Research Initiative marks 10th year of ‘big ideas’
November 12, 2018 | Michael Easterling
Now celebrating its 10th year, the Caltech and City of Hope Biomedical Research Initiative continues to change the future of science and medicine.
Minor diet changes can affect cancer risk, researcher finds
November 9, 2018 | City of Hope
On one hand, City of Hope's Rowan Chlebowski, M.D., Ph.D., is a medical oncologist and breast cancer expert. On the other, he’s a scientist specializing in observational studies who ranks among the most cited researchers in the world.
Groundbreaking new CAR T cell trial opens for patients with breast cancer that has spread to the brain
October 30, 2018 | Letisia Marquez
A new City of Hope chimeric antigen receptor (CAR) T cell trial – the first to focus on HER2-postive breast cancer patients with brain metastases – is now enrolling potential participants.